2,2'-dipicolylamine has been researched along with Leukemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Han, K; Hong, JI; Kim, YS; Park, HH; Rhee, HW | 1 |
Azeredo, NF; Borges, LJH; Bull, ÉS; Carvalho, ECQ; Fernandes, C; Freitas, WR; Horn, A; Jerdy, H; Kanashiro, MM; Lemos, LS; Resende, JALC | 1 |
2 other study(ies) available for 2,2'-dipicolylamine and Leukemia
Article | Year |
---|---|
Neutrophils with toxic granulation show high fluorescence with bis(Zn2+-dipicolylamine) complex.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amines; Bacterial Infections; Child; Female; Flavin-Adenine Dinucleotide; Granuloma; Hematopoietic Stem Cell Transplantation; Humans; Indicators and Reagents; Leukemia; Leukocyte Count; Male; Middle Aged; Neutrophils; Picolinic Acids; Sepsis; Young Adult | 2009 |
In vitro and in vivo studies of the antineoplastic activity of copper (II) compounds against human leukemia THP-1 and murine melanoma B16-F10 cell lines.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Coordination Complexes; Copper; Humans; Leukemia; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Pyridines | 2016 |